1. Home
  2. XOMAP vs SWIM Comparison

XOMAP vs SWIM Comparison

Compare XOMAP & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • SWIM
  • Stock Information
  • Founded
  • XOMAP N/A
  • SWIM 1956
  • Country
  • XOMAP United States
  • SWIM United States
  • Employees
  • XOMAP 13
  • SWIM N/A
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • SWIM Plastic Products
  • Sector
  • XOMAP Health Care
  • SWIM Industrials
  • Exchange
  • XOMAP Nasdaq
  • SWIM Nasdaq
  • Market Cap
  • XOMAP N/A
  • SWIM 751.3M
  • IPO Year
  • XOMAP N/A
  • SWIM 2021
  • Fundamental
  • Price
  • XOMAP $25.60
  • SWIM $5.65
  • Analyst Decision
  • XOMAP
  • SWIM Buy
  • Analyst Count
  • XOMAP 0
  • SWIM 4
  • Target Price
  • XOMAP N/A
  • SWIM $5.13
  • AVG Volume (30 Days)
  • XOMAP N/A
  • SWIM 638.8K
  • Earning Date
  • XOMAP N/A
  • SWIM 08-06-2024
  • Dividend Yield
  • XOMAP N/A
  • SWIM N/A
  • EPS Growth
  • XOMAP N/A
  • SWIM N/A
  • EPS
  • XOMAP N/A
  • SWIM 0.10
  • Revenue
  • XOMAP N/A
  • SWIM $522,395,999.00
  • Revenue This Year
  • XOMAP N/A
  • SWIM N/A
  • Revenue Next Year
  • XOMAP N/A
  • SWIM $8.02
  • P/E Ratio
  • XOMAP N/A
  • SWIM $55.36
  • Revenue Growth
  • XOMAP N/A
  • SWIM N/A
  • 52 Week Low
  • XOMAP N/A
  • SWIM $2.04
  • 52 Week High
  • XOMAP N/A
  • SWIM $6.68
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 58.55
  • SWIM 55.38
  • Support Level
  • XOMAP $25.29
  • SWIM $5.62
  • Resistance Level
  • XOMAP $25.38
  • SWIM $6.37
  • Average True Range (ATR)
  • XOMAP 0.11
  • SWIM 0.37
  • MACD
  • XOMAP 0.03
  • SWIM -0.14
  • Stochastic Oscillator
  • XOMAP 100.00
  • SWIM 12.02

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About SWIM Latham Group Inc.

Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.

Share on Social Networks: